Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 13 January 1978:
Vol. 199. no. 4325, pp. 197 - 198
DOI: 10.1126/science.202024

Articles

Science, Vol 199, Issue 4325, 197-198
Copyright © 1978 by American Association for the Advancement of Science


articles

Tricyclic antidepressants: therapeutic properties and affinity for alpha-noradrenergic receptor binding sites in the brain

DC U'Prichard, DA Greenberg, PP Sheehan, and SH Snyder

Tricyclic antidepressants vary in their capacity to cause psychomotor activation, to relieve agitated depressive states, and to cause sedation and hypotension. We have quantified relative potencies of tricyclic antidepressants in competing for the binding of 3H-labeled WB-4101 to alpha-noradrenergic receptor sites in rat brain membranes. Affinities of tricyclic drugs for alpha-noradrenergic receptor sites in the brain correlate well with the capacity of these agents to relieve psychomotor agitation and to induce sedation and hypotension; these affinities also correlate inversely with tendencies to elicit psychomotor activation.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Forty Years of Neurotransmitters: A Personal Account.
S. H. Snyder (2002)
Arch Gen Psychiatry 59, 983-994
   Abstract »    Full Text »    PDF »
Amitriptyline Reduces Myofascial Tenderness in Patients with Chronic Tension-Type Headache.
L Bendtsen and R Jensen (2000)
Cephalalgia 20, 603-610
   Abstract »    Full Text »    PDF »
Central Sensitization in Tension-Type Headache--Possible Pathophysiological Mechanisms.
L Bendtsen (2000)
Cephalalgia 20, 486-508
   Abstract »    Full Text »    PDF »
Inhibition of Na+ Current by Diphenhydramine and Other Diphenyl Compounds: Molecular Determinants of Selective Binding to the Inactivated Channels.
C.-C. Kuo, R.-C. Huang, and B.-S. Lou (2000)
Mol. Pharmacol. 57, 135-143
   Abstract »    Full Text »
Evaluation of Myocardial Cell Damage by In-111-Monoclonal Antimyosin Antibodies in Patients Under Chronic Tricyclic Antidepressant Drug Treatment.
V. Marti, M. Ballester, C. Udina, I. Carrio, E. Alvarez, D. Obrador, and G. Pons-Llado (1995)
Circulation 91, 1619-1623
   Abstract »    Full Text »
The role of noradrenaline in the differentiation of amphibian embryonic neurons.
S. J. Rowe, N. J. Messenger, and A. E. Warner (1993)
Development 119, 1343-1357
   Abstract »    PDF »
Tricyclic Antidepressants in the Intensive Care Unit.
G. W. Dec and T. A. Stern (1990)
J Intensive Care Med 5, 69-81
   Abstract »    PDF »
Tricyclic Antidepressants in the Treatment of Peptic Ulcer Disease.
J. C. Mangla and M. Pereira (1982)
Arch Intern Med 142, 273-275
   Abstract »    PDF »
Receptor Sensitivity and the Mechanism of Action of Antidepressant Treatment: Implications for the Etiology and Therapy of Depression.
D. S. Charney, D. B. Menkes, and G. R. Heninger (1981)
Arch Gen Psychiatry 38, 1160-1180
   Abstract »    PDF »
Cardiovascular Effects of Therapeutic Doses of Tricyclic Antidepressants: A Review.
A. H. Glassman and J. T. Bigger Jr (1981)
Arch Gen Psychiatry 38, 815-820
   Abstract »    PDF »
Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding.
S. Peroutka and S. Snyder (1980)
Science 210, 88-90
   Abstract »    PDF »
Clomipramine-Induced Mania in Unipolar Depression.
J. D. van Scheyen and D. P. van Kammen (1979)
Arch Gen Psychiatry 36, 560-565
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)